Sd-602 Sd Mode 11, Sd-603 Sd Mod 111
510(k) K925729
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK925729 | Date22 Jan 1993 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- GZJ
- Device Class
- Class II
- Regulation
- 21 CFR Part 882.5890
- Advisory Committee
- Neurology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The device is a medical device identified as SD-602 SD MODE 11 and SD-603 SD MOD 111, manufactured by Skylark Device Co., Ltd. It was determined to be substantially equivalent to a predicate device under a traditional 510(k) clearance process. The device was reviewed by the Neurology advisory committee and received FDA clearance on January 22, 1993, under K925729 with product code GZJ.
The device was submitted for clearance on November 13, 1992, and is authorized for distribution in the United States. It is manufactured at the address: 12 Floor 34, Sec. 3 Chung Shan, N. Rd., Taipei, Taiwan, R.O.C. No further details regarding sterility, single-use or reusable status, MRI safety, sizes, storage, or clinical indications are provided in the data.
Other devices from Skylark Device Co., Ltd.
Questions
AI-generated answers, 1 Oct 2026
What is the SD-602 SD MODE 11 and SD-603 SD MOD 111 device?
The SD-602 SD MODE 11 and SD-603 SD MOD 111 are medical devices manufactured by Skylark Device Co., Ltd., identified by their specific model names and cleared under FDA 510(k) K925729 as substantially equivalent to a predicate device.
How was the SD-602 SD MODE 11 and SD-603 SD MOD 111 cleared for market?
The device received FDA clearance through a traditional 510(k) submission process, where it was determined to be substantially equivalent to a legally marketed predicate device, based on review by the Neurology advisory committee.
When was the SD-602 SD MODE 11 and SD-603 SD MOD 111 cleared by the FDA?
The device was cleared by the FDA on January 22, 1993, under 510(k) number K925729, following its submission on November 13, 1992, after evaluation by the Neurology advisory committee.